Omalizumab in the treatment of spontaneous chronic urticaria in SUS in the state of Bahia - synthesis of evidence on efficacy, safety and simplified estimate of budgetary impact

To analyze and synthesize the available scientific research on the efficacy and safety of the treatment of patients with ECU, refractory antihistamines-H1, and to estimate the budgetary impact of their incorporation into SUS in Bahia. Methods: Synthesis of scientific tests, monitoring of simplified estimate of budgetary impact.